Evidence map›Paper›PMID 29279323›Full record

ArticleGenetics2018

The Hidden Genomic and Transcriptomic Plasticity of Giant Marker Chromosomes in Cancer.

Gemma Macchia, Marco Severgnini, Stefania Purgato, Doron Tolomeo, Hilen Casciaro, Ingrid Cifola, Alberto L'Abbate, Anna Loverro, Orazio Palumbo, Massimo Carella and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. TP53 in bone and soft tissue sarcomas.Pharmacology & therapeutics · 2019
    Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 3 countries.

Gemma MacchiaDepartment of Biology, University of Bari Aldo Moro, 70125 Italy gemma.macchia@uniba.it.
Marco SevergniniInstitute for Biomedical Technologies, Consiglio Nazionale delle Ricerche, Segrate, 20090 Italy.
Stefania PurgatoDepartment of Pharmacy and Biotechnology, University of Bologna, 40126 Italy.
Doron TolomeoDepartment of Biology, University of Bari Aldo Moro, 70125 Italy.
Hilen CasciaroDepartment of Biology, University of Bari Aldo Moro, 70125 Italy.ORCID 0000-0002-4323-6393
Ingrid CifolaInstitute for Biomedical Technologies, Consiglio Nazionale delle Ricerche, Segrate, 20090 Italy.
Alberto L'AbbateDepartment of Biology, University of Bari Aldo Moro, 70125 Italy.
Anna LoverroDepartment of Biology, University of Bari Aldo Moro, 70125 Italy.
Orazio PalumboLaboratorio di Genetica Medica, Istituto di Ricovero e Cura a Carattere Scientifico, Casa Sollievo della Sofferenza, San Giovanni Rotondo, 71013 Italy.ORCID 0000-0001-6583-3482
Massimo CarellaLaboratorio di Genetica Medica, Istituto di Ricovero e Cura a Carattere Scientifico, Casa Sollievo della Sofferenza, San Giovanni Rotondo, 71013 Italy.
Laurence BianchiniLaboratory of Solid Tumor Genetics, Université Côte d'Azur, Centre Nationnal de la Recherche Scientifique, Institute of Research on Cancer and Aging in Nice, 06108 France.
Giovanni PeriniDepartment of Pharmacy and Biotechnology, University of Bologna, 40126 Italy.
Gianluca De BellisInstitute for Biomedical Technologies, Consiglio Nazionale delle Ricerche, Segrate, 20090 Italy.
Fredrik MertensDepartment of Clinical Genetics, University and Regional Laboratories, Lund University, 22100 Sweden.
Mariano RocchiDepartment of Biology, University of Bari Aldo Moro, 70125 Italy.
Clelia Tiziana StorlazziDepartment of Biology, University of Bari Aldo Moro, 70125 Italy.
University of Bari Aldo Moro · ITInstitute of Biomedical Technologies · ITCasa Sollievo della Sofferenza · ITUniversity of Bologna · ITLund University · SEUniversité Côte d'Azur · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genome amplification in the form of rings or giant rod-shaped marker chromosomes (RGMs) is a common genetic alteration in soft tissue tumors. The mitotic stability of these structures is often rescued by perfectly functioning analphoid neocentromeres, which therefore significantly contribute to cancer progression. Here, we disentangled the genomic architecture of many neocentromeres stabilizing marker chromosomes in well-differentiated liposarcoma and lung sarcomatoid carcinoma samples. In cells carrying heavily rearranged RGMs, these structures were assembled as patchworks of multiple short amplified sequences, disclosing an extremely high level of complexity and definitely ruling out the existence of regions prone to neocentromere seeding. Moreover, by studying two well-differentiated liposarcoma samples derived from the onset and the recurrence of the same tumor, we documented an expansion of the neocentromeric domain that occurred during tumor progression, which reflects a strong selective pressure acting toward the improvement of the neocentromeric functionality in cancer. In lung sarcomatoid carcinoma cells we documented, extensive "centromere sliding" phenomena giving rise to multiple, closely mapping neocentromeric epialleles on separate coexisting markers occur, likely due to the instability of neocentromeres arising in cancer cells. Finally, by investigating the transcriptional activity of neocentromeres, we came across a burst of chimeric transcripts, both by extremely complex genomic rearrangements, and

Indexed as

Chromosomes, HumanGenetic MarkersGenomicsTranscriptomeCell Line, TumorCentromereHumansIn Situ Hybridization, FluorescenceNeoplasmsPolymorphism, Single NucleotideTranscription, GeneticWhole Genome SequencingGenetic Markersfusion transcriptgene amplificationLSCneocentromereWDLPS

Identifiers

PMID29279323
PMCPMC5844343
OpenAlexW2778879300

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.